What does CUSIP 88025U109 represent in this 13F holders report?

CUSIP 88025U109 is the security identifier for TXG - 10x Genomics, Inc. - CLASS A COMMON STOCK used to aggregate holder disclosures.

How many institutions held TXG - 10x Genomics, Inc. - CLASS A COMMON STOCK in Q1 2021?

310 institutional investors reported TXG - 10x Genomics, Inc. - CLASS A COMMON STOCK for Q1 2021. Use the holders table for investor-level position and value details.

10x Genomics, Inc. - CLASS A COMMON STOCK (TXG)

CUSIP: 88025U109

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / CLASS A COMMON STOCK
Shares outstanding: 118,868,985
Total 13F shares: 70,505,001
Share change: +4,294,484
Total reported value: $12,760,866,584
Put/Call ratio: 139%
Price per share: $181.00
Number of holders: 310
Value change: +$832,242,795
Number of buys: 192
Number of sells: 143

Quarterly Holders Quick Answers

What is CUSIP 88025U109?
CUSIP 88025U109 identifies TXG - 10x Genomics, Inc. - CLASS A COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 88025U109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TXG - 10x Genomics, Inc. - CLASS A COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	8.5%	10,071,083	$1,426,065,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	5.6%	6,706,419	$949,628,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	5.2%	6,187,705	$876,179,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	4.3%	5,163,020	$731,084,000	—	31 Dec 2020	13F
Meritech Capital Associates V L.L.C.	13F	Company	2.2%	2,580,975	$365,466,000	—	31 Dec 2020	13F
Foresite Capital Management II, LLC	13F	Company	2.1%	2,503,528	$354,500,000	—	31 Dec 2020	13F
12 West Capital Management LP	13F	Company	1.6%	1,922,000	$272,155,000	—	31 Dec 2020	13F
Venrock Management VI, LLC	13F	Company	1.6%	1,889,497	$267,553,000	—	31 Dec 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	1.2%	1,371,634	$194,220,000	—	31 Dec 2020	13F
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	13F	Company	1.1%	1,282,261	$181,568,000	—	31 Dec 2020	13F
Foresite Capital Management I, LLC	13F	Company	1.1%	1,250,000	$177,000,000	—	31 Dec 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.96%	1,138,699	$161,240,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	0.93%	1,105,115	$156,484,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.91%	1,080,745	$153,034,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	0.9%	1,071,547	$151,731,000	—	31 Dec 2020	13F
CREDIT SUISSE AG/	13F	Company	0.77%	909,512	$128,786,000	—	31 Dec 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.72%	856,286	$121,250,000	—	31 Dec 2020	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.67%	796,655	$112,806,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.66%	788,106	$111,468,000	—	31 Dec 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.66%	782,325	$110,777,000	—	31 Dec 2020	13F
BAILLIE GIFFORD & CO	13F	Company	0.65%	775,020	$109,743,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.63%	749,531	$106,134,000	—	31 Dec 2020	13F
RTW INVESTMENTS, LP	13F	Company	0.56%	660,933	$93,588,000	—	31 Dec 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.52%	621,108	$87,948,892	—	31 Dec 2020	13F
JS Capital Management LLC	13F	Company	0.5%	599,447	$84,882,000	—	31 Dec 2020	13F
BAMCO INC /NY/	13F	Company	0.5%	596,882	$84,518,000	—	31 Dec 2020	13F
LORD, ABBETT & CO. LLC	13F	Company	0.49%	578,226	$81,877,000	—	31 Dec 2020	13F
ARK Investment Management LLC	13F	Company	0.45%	533,496	$75,543,000	—	31 Dec 2020	13F
BROWN CAPITAL MANAGEMENT LLC	13F	Company	0.39%	458,241	$64,887,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.39%	457,685	$64,809,000	—	31 Dec 2020	13F
JENNISON ASSOCIATES LLC	13F	Company	0.37%	444,609	$62,957,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.34%	398,626	$56,446,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.33%	395,731	$56,036,000	—	31 Dec 2020	13F
WADDELL & REED FINANCIAL INC	13F	Company	0.31%	364,779	$51,653,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.29%	339,463	$48,068,000	—	31 Dec 2020	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	0.27%	316,950	$44,880,000	—	31 Dec 2020	13F
FIRST TRUST ADVISORS LP	13F	Company	0.27%	315,594	$44,688,000	—	31 Dec 2020	13F
EATON VANCE MANAGEMENT	13F	Company	0.23%	270,785	$38,343,000	—	31 Dec 2020	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.22%	261,803	$37,071,000	—	31 Dec 2020	13F
FIL Ltd	13F	Company	0.22%	261,061	$36,967,000	—	31 Dec 2020	13F
MARSHALL WACE, LLP	13F	Company	0.22%	257,149	$36,412,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.21%	249,242	$35,293,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.2%	231,900	$32,837,000	—	31 Dec 2020	13F
Point72 Asset Management, L.P.	13F	Company	0.18%	209,738	$29,699,000	—	31 Dec 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.17%	206,017	$29,172,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.17%	205,881	$29,153,000	—	31 Dec 2020	13F
D1 Capital Partners L.P.	13F	Company	0.16%	191,336	$27,093,000	—	31 Dec 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.15%	180,632	$25,578,000	—	31 Dec 2020	13F
AMUNDI ASSET MANAGEMENT US, INC.	13F	Company	0.15%	174,263	$24,676,000	—	31 Dec 2020	13F
Legal & General Group Plc	13F	Company	0.14%	172,008	$24,356,000	—	31 Dec 2020	13F

Institutional Holders of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) as of Q1 2021

As of 31 Mar 2021, 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) was held by 310 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 70,505,001 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Inc., MORGAN STANLEY, ARK Investment Management LLC, Foresite Capital Management II, LLC, Meritech Capital Associates V L.L.C., 12 West Capital Management LP, AMERIPRISE FINANCIAL INC, and BAILLIE GIFFORD & CO. This page lists 311 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

299

Q1 2021 holders

310

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.